Biome Grow enters into supply & production contract with Cannabis NB

By Nikita Chaurasia  Date: 2019-08-13

Biome Grow enters into supply & production contract with Cannabis NB
  • Initially Biome subsidiary, Highland Grow Inc., will supply cannabis products in Nova Scotia.
  • Biome also looks forward to expands its footprints across other provinces of Canada.

Biome Grow Inc., a Toronto based cannabis and CBD products providing company, reportedly announced that it would start cannabis retail sales in the regions of New Brunswick. Biome Grow has signed a supply and production agreement with Cannabis NB. Highland Grow Inc., one of the subsidiaries of Biome, based in Nova Scotia will supply cannabis products initially.

Biome’s CEO, Khurram Malik stated that the company is focused on the region of Atlantic Canada and thus adding distribution in New Brunswick was important. The company’s high quality pre-rolls and premium flower are popular in Nova Scotia, Labrador, Newfoundland and in Saskatchewan with good feedback of customers.

Malik also stated that the company is thrilled to be an approved provider in New Brunswick allowing the company to introduce its brand to cannabis savants in the region.

Lara Wood, General Manager, Cannabis NB Ltd., stated that the company is thrilled to have Biome as its newest supply partner and look forward to launching the product successfully in their retail network. Lara added that the company is planning to add Biome’s products to the company’s portfolio and expand the options provided to customers in New Brunswick.

Biome has continued its development of cannabis from the start of commercial sales in January 2019. Management looks ahead to share its plans to increase its production and commercial aspects to other Canadian provinces in the coming months.

About Biome Grow Inc.

Over five subsidiaries are wholly owned by Biome Grow Inc., some of which are Great Lakes Cannabis, Highland Grow Inc., Weed Virtual Retail Inc. Biome is based in Toronto, Canada having business in international and national markets.

 

Source Credit:

https://www.globenewswire.com/news-release/2019/08/12/1900404/0/en/Biome-Grow-Announces-Supply-Agreement-With-Cannabis-NB.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

1health to offer two types of COVID-19 testing kits to SkyWest Airlines

1health to offer two types of COVID-19 testing kits to SkyWest Airlines

By Nikita Chaurasia

Leading Testing as a Service (TaaS) provider, 1health, recently announced that it has partnered with SkyWest Airlines, a SkyWest Inc. subsidiary, to provide two types of COVID-19 tests to the airline’s personnel. Mehdi Maghsoodnia, CEO at 1hea...

FBI to remove backdoors from hacked Microsoft Exchange email servers

FBI to remove backdoors from hacked Microsoft Exchange email servers

By Nikita Chaurasia

Following the recent cyber-attack in the US, a court in Houston has reportedly authorized a new FBI operation to copy and eliminate backdoors from large number of Microsoft Exchange email servers across the country. During this hacking event, the hac...

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...